
Join to View Full Profile
2020 Genesee AveSan Diego, CA 92123
Phone+1 858-616-8091
Fax+1 858-616-8090
Dr. Minuto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joshua Minuto is an infectious disease specialist based in San Diego, CA. He completed his internal medicine residency at Scripps Mercy Hospital from 2002 to 2005, followed by a fellowship in infectious disease at the University of California (San Diego) Medical Center from 2006 to 2009. He earned his medical degree from the University of California San Diego School of Medicine in 2002. Dr. Minuto has several publications, including studies on tuberculosis in HIV patients and health issues among injection drug users, which have been cited multiple times in other works.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Infectious Disease, 2006 - 2009
- Scripps Mercy HospitalResidency, Internal Medicine, 2002 - 2005
- University of California San Diego School of MedicineClass of 2002
Certifications & Licensure
- AZ State Medical License 2024 - 2027
- NM State Medical License 2023 - 2027
- ID State Medical License 2024 - 2026
- CA State Medical License 2003 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 16 citationsTuberculosis due to Mycobacterium bovis in Patients Coinfected with Human Immunodeficiency VirusDaniel Park, Huifang Qin, Sonia Jain, Michael Preziosi, Joshua J. Minuto
Clinical Infectious Diseases. 2010-12-01 - 41 citationsHigh prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico.Robin A. Pollini, Manuel Gallardo, Samreen Hasan, Joshua J Minuto, Remedios Lozada
International Journal of Infectious Diseases. 2010-09-01 - 18 citationsEtravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection.Joshua J Minuto, Richard Haubrich
Future HIV Therapy. 2008-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: